rs4252170

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000301.5(PLG):​c.2082T>C​(p.Ala694Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0771 in 1,612,254 control chromosomes in the GnomAD database, including 5,221 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.063 ( 385 hom., cov: 33)
Exomes 𝑓: 0.078 ( 4836 hom. )

Consequence

PLG
NM_000301.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.02
Variant links:
Genes affected
PLG (HGNC:9071): (plasminogen) The plasminogen protein encoded by this gene is a serine protease that circulates in blood plasma as an inactive zymogen and is converted to the active protease, plasmin, by several plasminogen activators such as tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and factor XII (Hageman factor). The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562. Plasmin cleavage also releases the angiostatin protein which inhibits angiogenesis. Plasmin degrades many blood plasma proteins, including fibrin-containing blood clots. As a serine protease, plasmin cleaves many products in addition to fibrin such as fibronectin, thrombospondin, laminin, and von Willebrand factor. Plasmin is inactivated by proteins such as alpha-2-macroglobulin and alpha-2-antiplasmin in addition to inhibitors of the various plasminogen activators. Plasminogen also interacts with plasminogen receptors which results in the retention of plasmin on cell surfaces and in plasmin-induced cell signaling. The localization of plasminogen on cell surfaces plays a role in the degradation of extracellular matrices, cell migration, inflamation, wound healing, oncogenesis, metastasis, myogenesis, muscle regeneration, neurite outgrowth, and fibrinolysis. This protein may also play a role in acute respiratory distress syndrome (ARDS) which, in part, is caused by enhanced clot formation and the suppression of fibrinolysis. Compared to other mammals, the cluster of plasminogen-like genes to which this gene belongs has been rearranged in catarrhine primates. [provided by RefSeq, May 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 6-160741374-T-C is Benign according to our data. Variant chr6-160741374-T-C is described in ClinVar as [Benign]. Clinvar id is 1268733.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-160741374-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.02 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0904 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLGNM_000301.5 linkc.2082T>C p.Ala694Ala synonymous_variant Exon 17 of 19 ENST00000308192.14 NP_000292.1 P00747

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLGENST00000308192.14 linkc.2082T>C p.Ala694Ala synonymous_variant Exon 17 of 19 1 NM_000301.5 ENSP00000308938.9 P00747

Frequencies

GnomAD3 genomes
AF:
0.0634
AC:
9653
AN:
152240
Hom.:
382
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0185
Gnomad AMI
AF:
0.0581
Gnomad AMR
AF:
0.0651
Gnomad ASJ
AF:
0.0772
Gnomad EAS
AF:
0.0976
Gnomad SAS
AF:
0.0553
Gnomad FIN
AF:
0.0989
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.0815
Gnomad OTH
AF:
0.0798
GnomAD3 exomes
AF:
0.0740
AC:
18616
AN:
251476
Hom.:
757
AF XY:
0.0742
AC XY:
10089
AN XY:
135914
show subpopulations
Gnomad AFR exome
AF:
0.0183
Gnomad AMR exome
AF:
0.0554
Gnomad ASJ exome
AF:
0.0886
Gnomad EAS exome
AF:
0.0969
Gnomad SAS exome
AF:
0.0530
Gnomad FIN exome
AF:
0.101
Gnomad NFE exome
AF:
0.0824
Gnomad OTH exome
AF:
0.0902
GnomAD4 exome
AF:
0.0785
AC:
114579
AN:
1459896
Hom.:
4836
Cov.:
30
AF XY:
0.0775
AC XY:
56265
AN XY:
726420
show subpopulations
Gnomad4 AFR exome
AF:
0.0184
Gnomad4 AMR exome
AF:
0.0577
Gnomad4 ASJ exome
AF:
0.0863
Gnomad4 EAS exome
AF:
0.113
Gnomad4 SAS exome
AF:
0.0517
Gnomad4 FIN exome
AF:
0.0982
Gnomad4 NFE exome
AF:
0.0805
Gnomad4 OTH exome
AF:
0.0825
GnomAD4 genome
AF:
0.0634
AC:
9659
AN:
152358
Hom.:
385
Cov.:
33
AF XY:
0.0638
AC XY:
4753
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.0185
Gnomad4 AMR
AF:
0.0651
Gnomad4 ASJ
AF:
0.0772
Gnomad4 EAS
AF:
0.0975
Gnomad4 SAS
AF:
0.0547
Gnomad4 FIN
AF:
0.0989
Gnomad4 NFE
AF:
0.0815
Gnomad4 OTH
AF:
0.0855
Alfa
AF:
0.0808
Hom.:
1332
Bravo
AF:
0.0592
Asia WGS
AF:
0.128
AC:
446
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 09, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.098
DANN
Benign
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4252170; hg19: chr6-161162406; COSMIC: COSV57516701; API